comparemela.com

Latest Breaking News On - Himanshu gadgil - Page 2 : comparemela.com

How a scientist at Enzene is rethinking manufacturing to make anti-cancer drugs affordable in India

Anti-cancer drugs are beyond the reach of average Indian patients. Early-stage patients spend up to INR6 lakh on medicines alone. For advanced stages, the cost is higher. Scientist Himanshu Gadgil gave up a cushy job in the US and returned to India with a mission. Pioneering a unique manufacturing process, he is changing the game, one drug at a time.

Enzene rolls out biosimilar of Roche s cancer drug bevacizumab

Enzene rolls out biosimilar of Roche s cancer drug bevacizumab
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Pune biotech firm announces cheaper drug for colorectal cancer

"We are confident that the significant price reductions passed on by our partners will greatly benefit thousands of metastatic colorectal cancer patients, supporting our mission to make cancer treatment more accessible and affordable," he added.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.